Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Total Expenditure

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Expenditure ₹167 Cr₹130 Cr₹122 Cr₹104 Cr₹63 Cr

What is the latest Total Expenditure of KILITCH DRUGS (INDIA) ?

The latest Total Expenditure ratio of KILITCH DRUGS (INDIA) is ₹167 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹167 Cr
Mar2024₹130 Cr
Mar2023₹122 Cr
Mar2022₹104 Cr
Mar2021₹63 Cr

How is Total Expenditure of KILITCH DRUGS (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹167 Cr
28.03
Mar2024 ₹130 Cr
6.76
Mar2023 ₹122 Cr
17.48
Mar2022 ₹104 Cr
64.11
Mar2021 ₹63 Cr -

Compare Total Expenditure of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹622.9 Cr 9.9% 2.3% 20% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

9.9%

2.3%

20%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses